A huge international medical trial could be a gamechanger for millions of people at risk of getting Alzheimer’s disease.
Researchers at 60 sites in the United States, Canada and Australia are getting ready to test an antibody that they believe could break-up a dangerous form of plaque that builds in the brain.
It is called amyloid plaque and this abnormal protein has the ability to kill nerve cells, triggering the dementia of Alzheimer’s.
The theory goes, detect the plaque early, destroy it, and the disease will never take hold.
For many years that was an illusive goal because the only way to find the plaque was through an autopsy. But a new form of imaging – the PET scan — is giving doctors the ability to find amyloid plaque years before the first symptoms of Alzheimer’s appear.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Study offers help for LGBTQ seniors or caregivers dealing with Alzheimers, dementiaon February 22, 2021 at 6:17 am
Study at the University of Washington is offering a free program for individuals with memory loss and their care partners. Either the person with memory loss or their care partner must be LGBTQ to ...
- Alzheimers Q&A: Is excessive crying normal in Alzheimer's disease?on February 22, 2021 at 2:00 am
Some people with Alzheimers, as the disease progresses and cognitive functions decline, may cry excessively whether or not they are unhappy. He or she cannot control the display of emotions, ...
- Cortexyme Provides Regulatory Update on Development Program for Atuzaginstat in Alzheimers Diseaseon February 16, 2021 at 10:25 am
(NASDAQ: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer’s and other degenerative diseases, received a letter from the U.S. Food and Drug Administration (FDA) stating that a ...
- The Sum Total Of Our Memory: Facing Alzheimers Together (2014)on February 13, 2021 at 4:00 pm
An ode to memory: Couples affected by a partner's recent diagnosis of Early Alzheimer's come to terms with their changing roles. Prominent Alzheimer's medical experts offer their perspectives on ...
- Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimers diseaseon February 11, 2021 at 1:32 am
Exscientia, a leading AI Drug Discovery company, has today announced its collaboration with the Alzheimer’s Research UK University of Oxford Drug Discovery Institute (ARUK-ODDI) to develop medicines ...
- Research highlights new Alzheimers markeron February 10, 2021 at 6:00 am
A team of researchers at the Institut national de la recherche scientifique (INRS) team has identified two early markers in plasma that can detect Alzheimer’s disease five years before its ...
- Personal trainer provides gentle exercise for Alzheimer's, dementia familieson February 5, 2021 at 10:04 am
Since 2018, when Alzheimers Coachella Valley launched Club Journey, its popular socially interactive program for families facing Alzheimer’s and dementia, professional trainer Kristi-Lynn Lake ...
- Alzheimers Drugs Market: 2019 Industry Analysis, Size, Trends, Growth and Forecast 2030 - H. Lundbeck A/S, Eisai Co, Avanir Pharmaceuticalson February 3, 2021 at 2:26 am
Alzheimer’s drugs are the medications that reduce the symptoms of the disease or in few cases also control the behavioral symptoms. At present, no medication is prescribed for the said disease.
- Woman with Alzheimers freezes to death after wandering from homeon February 1, 2021 at 4:14 pm
The enormous massive snow storm hitting the Northeast has claimed the life of a Pennsylvania woman who had wandered away from her home. Patricia Becker, 67, who suffered from Alzheimer's disease ...
- Alzheimers Q&A: Why is it so hard time to say the word 'Alzheimer's' or recognize the disease itself?on February 1, 2021 at 4:00 am
It is difficult for people to talk about Alzheimer's because it is a fearful and debilitating disease that affects over 5 million Americans.
via Bing News